Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis

BACKGROUND/AIMS: Previous studies have revealed that glucagon-like peptide-1 receptor agonist (GLP-1RA) and thiazolidinedione (TZD) can improve nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH). However, comprehensive research comparing the effects of GLP-1RA and TZD is...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Min Jeong, Kim, Hayeon, Kim, Myeong Gyu, Kim, Kyungim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366812/
https://www.ncbi.nlm.nih.gov/pubmed/36907574
http://dx.doi.org/10.3350/cmh.2022.0330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366812/
https://www.ncbi.nlm.nih.gov/pubmed/36907574
http://dx.doi.org/10.3350/cmh.2022.0330

Ejemplares similares